SNG001 Anti-Viral
We have discovered and developed a new anti-viral drug (SNG001) that could potentially help reduce the number of hospital admissions for asthma, bronchitis and emphysema as well as potentially reduce deaths in these patients triggered by respiratory viruses such as the common cold or influenza. Our company Synairgen, founded by Professors at the University of Southampton to […]